CLINICAL EVENTS CALENDAR
- Mar 11,2010Mar 14,2010Midwest Podiatry Conference03/11/2010 - 10:4203/14/2010 - 10:42website:
Hyatt Regency, Chicago, IL
- Apr 08,2010Apr 11,2010Update 2010: Reconstructive Surgery of the Foot & Ankle04/08/2010 - 10:4304/11/2010 - 10:43website:
Podiatry Institute
Crowne Plaza Ravinia, Atlanta, GA - Apr 17,2010Apr 20,20102010 SAWC Spring04/17/2010 - 11:2304/20/2010 - 11:23website:
Gaylord Palms Hotel and Convention Center
Orlando, FL - Apr 29,2010May 02,2010Surgical Pearls by the Sea: Current Trends in Foot and Ankle Surgery04/29/2010 - 10:4405/02/2010 - 10:44website:
Podiatry Institute
Newport Marriott, Newport, RI
Non-Accredited Education
Managing the Diabetic Foot: A Clinical and Economic View Complimentary Archived Webcast
Non-Accredited
Understanding Collagen Dressings and their Benefit in Wound Care![]()
Complimentary Archived Webcast
non-accredited
Diabetes Watch
When There Are Acute Changes In Mental Status In Patients With Diabetes
As podiatric physicians in 2010, we are better trained than ever to manage patients’ problems. Even more importantly, we are well versed in making appropriate, well-timed referrals when needed. In the following case study, that particular acumen was critically important.
Can Curative Foot Surgery Facilitate The Healing Of Diabetic Foot Ulcers?
Up to 25 percent of people with diabetes will develop a foot ulceration at some point during their lifetimes.1 There are a number of component causes that interact to complete the causal pathway to foot ulceration. However, the most frequent component causes are peripheral neuropathy, deformity and trauma.2,3
Deformity leads to increased plantar pressures and when these are combined with sensory neuropathy, ulcer formation is likely. Therefore, one must consider foot deformities as a possible cause for all foot ulcers.
Examining The Role Of NPWT In Limb Salvage
Diabetic foot ulcerations are a significant public health concern and cause an increasingly heavy demand on our healthcare systems. Diabetic foot infections cause more than 300,000 admissions to hospitals each year, leading to approximately 92,000 amputations.1 The resulting wounds require intensive local wound care and are slow to heal, resulting in prolonged disability and hospitalization.
Can Nanotechnology Have An Impact For Patients With Diabetes?
Regardless of their specialty, clinicians will encounter patients who are affected by diabetes mellitus, infection and wound healing issues. Therefore, the emerging, evolving science of nanomedicine and how this technology could positively enhance patient outcomes would be of great interest to all physicians including DPMs.
Current Concepts In Treating Diabetic Foot Osteomyelitis
Diabetic foot osteomyelitis continues to be one of the more challenging entities to diagnose and treat accurately. Although there are established clinical practice guidelines set forth by the Infectious Diseases Society of America (IDSA), deviations from these guidelines often exist from one treatment facility to the next.1
Current Concepts In Offloading Diabetic Foot Ulcers
As the prevalence of diabetes mellitus increases worldwide, there will be a concomitant increase in the development of the lower extremity manifestations of the disease process. In the United States alone, there are currently an estimated 24 million patients living with diabetes.1,2 Given the reported 15 percent lifetime incidence for the development of lower extremity ulcerations in this patient population, this equates to approximately 3.6 million diabetic foot ulcers (DFUs).3
Is HbA1c A Reliable Test In Patients With Diabetes And Renal Disease?
Reportedly 23.6 million individuals in the United States (or 8 percent of the American population) are affected by diabetes.1 Many of those with diabetes will develop related comorbidities such as microvascular pathology in the retina, renal glomeruli and peripheral nerves. Other comorbidities include accelerated atherosclerotic microvascular disease affecting arteries that supply the heart, brain and lower extremities.2,3
Can New Hemostatic Dressings Facilitate Sharp Debridement In High-Risk Patients?
Sharp debridement is a critical step to promote healing and allow the body to repair chronic wounds as naturally and healthily as possible. Removing necrotic tissue and biofilm from the surface of chronic wounds converts chronic wounds into acute ones, effectively “resetting” the wound healing cascade and allowing the healing process to take place.
Is HBOT Cost-Effective For Diabetic Foot Ulcers?
It is estimated that Medicare spends $1.5 billion annually to treat diabetic foot ulcers (DFU).1 The debate continues on the cost effectiveness of immediate amputation in comparison with “conservative treatment” using a variety of modalities.
Gretna, Louisiana
CME Showcase
"Current Concepts In Healing Chronic Diabetic Foot Ulcerations"
A Complimentary On-Demand CE/CME Webcast This activity is supported by an educational grant from Advanced Biohealing. To access this Webcast, visit www.naccme.com/program/n-550/ |

















